Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure.
Pengo V, Hoxha A, Andreoli L, Tincani A, Silvestri E, Prisco D, Fierro T, Gresele P, Cafolla A, De Micheli V, Ghirarduzzi A, Tosetto A, Falanga A, Martinelli I, Testa S, Barcellona D, Gerosa M, Denas G. Pengo V, et al. Among authors: fierro t. J Thromb Haemost. 2021 Feb;19(2):531-535. doi: 10.1111/jth.15158. Epub 2020 Nov 29. J Thromb Haemost. 2021. PMID: 33128325 Free article. Clinical Trial.
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.
Pengo V, Denas G, Zoppellaro G, Jose SP, Hoxha A, Ruffatti A, Andreoli L, Tincani A, Cenci C, Prisco D, Fierro T, Gresele P, Cafolla A, De Micheli V, Ghirarduzzi A, Tosetto A, Falanga A, Martinelli I, Testa S, Barcellona D, Gerosa M, Banzato A. Pengo V, et al. Among authors: fierro t. Blood. 2018 Sep 27;132(13):1365-1371. doi: 10.1182/blood-2018-04-848333. Epub 2018 Jul 12. Blood. 2018. PMID: 30002145 Free article. Clinical Trial.
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study.
Pengo V, Ruffatti A, Legnani C, Testa S, Fierro T, Marongiu F, De Micheli V, Gresele P, Tonello M, Ghirarduzzi A, Bison E, Denas G, Banzato A, Padayattil Jose S, Iliceto S. Pengo V, et al. Among authors: fierro t. Blood. 2011 Oct 27;118(17):4714-8. doi: 10.1182/blood-2011-03-340232. Epub 2011 Jul 15. Blood. 2011. PMID: 21765019 Free article.
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry).
Calabrò P, Moscarella E, Gragnano F, Cesaro A, Pafundi PC, Patti G, Cavallari I, Antonucci E, Cirillo P, Pignatelli P, Palareti G, Sasso FC, Pengo V, Gresele P, Marcucci R; START-ANTIPLATELET collaborators; Conte M, Fimiani F, Di Serafino L, Del Pinto M, Denas G, Pastori D, Eleonora C, Fierro T. Calabrò P, et al. Among authors: fierro t. Am J Cardiol. 2019 Dec 1;124(11):1662-1668. doi: 10.1016/j.amjcard.2019.08.030. Epub 2019 Sep 6. Am J Cardiol. 2019. PMID: 31585697
Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry.
Gresele P, Guglielmini G, Del Pinto M, Calabrò P, Pignatelli P, Patti G, Pengo V, Antonucci E, Cirillo P, Fierro T, Palareti G, Marcucci R; START Antiplatelet Registry Group. Gresele P, et al. Among authors: fierro t. Int J Cardiol. 2021 Mar 15;327:176-182. doi: 10.1016/j.ijcard.2020.10.079. Epub 2020 Nov 3. Int J Cardiol. 2021. PMID: 33152418
30 results